512217-BOM

Prism Medico and Pharmacy Ltd.

28.90+1.9 (+7.12%)
27 Jul, 12:00 AM

Annual Reports and Financial Documents

Prism Medico and Pharmacy Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
201320142015201620172018201920202021202220232025
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Prism Medico and Pharmacy Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General21 Jul 2026
    Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
    Dear Sir/Madam, Please find the attache statements of investor complaints for the quarter ended 30th June, 2026. You are requested to kindly take the same on record and oblige. Thanking ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Dear Sir/ Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find the attached certificate issued ....
  • 57 (5) : intimation after the end of quarter6 Jul 2026
    Compliance-57 (5) : intimation after the end of quarter
    Dear Sir/Madam, Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find the attached intimation for your reference and ....
  • 57 (4) : Prior intimation to the beginning of the quarter30 Jun 2026
    Compliance-57 (4) : Prior intimation to the beginning of the quarter
    Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), please find the attached intimation ....
  • Closure of Trading Window30 Jun 2026
    Closure of Trading Window
    Pursuant to Code of Conduct to regulate, monitor and report trading by insiders (''Code'') and applicable SEBI Regulations, please find the attached intimation letter that the trading window ....
  • Outcome of Board Meeting28 May 2026
    Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
  • Board Meeting23 May 2026
    Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve With reference to ....
  • Outcome without intimation11 May 2026
    Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors ....
  • Allotment of Equity Shares5 May 2026
    Announcement under Regulation 30 (LODR)-Allotment
    With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....
  • Outcome without intimation5 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Securities
    With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....
  • General29 Apr 2026
    Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework.
    Dear Sir/Madam, Please find the attached confirmation regarding non-applicability of large corporate entity framework. You are requested to take the same on record and oblige. Thanks ....
  • General21 Apr 2026
    Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
    Dear Sir/Madam, Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find the attached certificate from the RTA for the ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find the attached certificate issued ....
  • 57 (5) : intimation after the end of quarter7 Apr 2026
    Compliance-57 (5) : intimation after the end of quarter
    Dear Sir/ Madam, Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find attached the intimation. Kindly take the same ....
  • General7 Apr 2026
    Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 For The Financial Year Ended 31St March, 2026.
    Dear Sir/Madam, Pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find attached the attached disclosure for your reference ....
  • 57 (5) : intimation after the end of quarter6 Apr 2026
    Compliance-57 (5) : intimation after the end of quarter
    Dear Sir/Madam, Please find the attached intimation under Regulation 57(5) of SEBI (LODR) Regulations, 2015. You are requested to kindly take the same on record and acknowledge the ....
  • General30 Mar 2026
    Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Dear Sir/Madam, Please find the attached intimation under Regulation 57(4) of SEBI (LODR) Regulations, 2015. Kindly take the same on record and oblige. Thanking You.
  • Closure of Trading Window30 Mar 2026
    Closure of Trading Window
    Dear Sir/Madam, Pursuant to Code of Conduct to regulate, monitor and report Trading by Insider ("Code") and applicable SEBI Regulations, please find the attached intimation of closure ....
  • General30 Mar 2026
    Clarification With Respect To Significant Movement In The Price Of Our Security At The Stock Exchange.
    Dear Sir/Madam, Please find the attached reply to significant movement in the price of our security in the stock exchange. You are requested to take the same on record and oblige. ....
  • EGM24 Mar 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Dear Sir/Madam, Pursuant to the provisions of Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 and provision of Regulation ....

Frequently Asked Questions

Where can I download the annual report of Prism Medico and Pharmacy Ltd.?
Annual reports of Prism Medico and Pharmacy Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Prism Medico and Pharmacy Ltd.?
Quarterly earnings results and presentations of Prism Medico and Pharmacy Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Prism Medico and Pharmacy Ltd. publish earnings call transcripts?
Earnings call transcripts of Prism Medico and Pharmacy Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Prism Medico and Pharmacy Ltd.?
Investor presentations and annual day presentations of Prism Medico and Pharmacy Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Prism Medico and Pharmacy Ltd.?
Corporate announcements and regulatory filings of Prism Medico and Pharmacy Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Prism Medico and Pharmacy Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Prism Medico and Pharmacy Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Prism Medico and Pharmacy Ltd.?
The ISIN (International Securities Identification Number) of Prism Medico and Pharmacy Ltd. is INE730E01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Prism Medico and Pharmacy Ltd. listed?
Prism Medico and Pharmacy Ltd. is listed on NSE and BSE. The NSE symbol is 512217-BOM and the BSE code is -.
Where can I find the shareholding pattern of Prism Medico and Pharmacy Ltd.?
The quarterly shareholding pattern of Prism Medico and Pharmacy Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Prism Medico and Pharmacy Ltd. on Sharpely?
Share price data for Prism Medico and Pharmacy Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.